Bellvitge and IDIBELL lead a study on the effectiveness of icatibant against COVID-19

by Hospital Universitari de Bellvitge

​Bellvitge University Hospital and Bellvitge Biomedical Research Institute (IDIBELL) had launched a clinical study, along with the pharmaceutical company Takeda, to evaluate the efficacy and safety ...

Read more

Un nuevo fármaco para tratar las fístulas de Crohn se basa en una tecnología del CSIC con células madre

by DiCYT - Agencia Iberoamericana para la Difusión de la Ciencia y la Tecnología

Se fundamenta en una patente de investigadores del Instituto de Parasitología y Biomedicina López Neyra, licenciada a la farmacéutica japonesa Takeda, que comercializa el fármaco

Read more

Takeda and TiGenix Announce the Results of the Phase 3 ADMIRE-CD Trial Investigating Cx601 in the Treatment of Complex Perianal Fistulas in Patients with Crohn’s Disease

by TIGENIX SAU

Takeda and TiGenix Announce Publication in The Lancet of 24-Week Results of the Phase 3 ADMIRE-CD Trial Investigating Cx601 in the Treatment of Complex Perianal Fistulas in Patients with Crohn’s Dis...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Some regions of the human genome conside...

by Universitat de Barcelona

Many repetitive regions of the genome have been considered “junk DNA...

Photos Stream